Solid Tumor Oncology RWE Science & Epidemiology Manager
Pfizer Inc.
New York City, NY
Job posting number: #7214377 (Ref:pf-4905897)
Posted: February 6, 2024
Job Description
ROLE SUMMARY
The Platform: The Chief Medical Affairs Office’s Real World Evidence (RWE) Platform is responsible for establishing global scientific leadership and stature through the generation of integrated, end-to-end observational real-world evidence serving all therapeutic areas from proof of concept (POC) trials through LOE for priority pipeline candidates, pipeline supplementation through business development, and marketed inline products. The Platform fully centralizes RWE, epidemiology, outcomes research, RW-relevant health informatics, and biostatistics talent from global, US, international markets into one team to drive efficiency through internalized work.
The Platform functions to:
Enhance Pfizer’s ability to determine unmet medical needs; support differentiated product labels for Product Development programs including finding alternatives and accelerated licensure pathways for new indications through the use of Real World Data (RWD), Real World Insights (RWI) and Real World Evidence (RWE); inform clinical practice on appropriate prescription and use of Pfizer’s products; in collaboration with Access & Value, strengthen the value evidence package for payers and access/policy decision-makers; support measurement of short- and long-term impact of Pfizer’s products to both patients and populations; support competitive differentiation.
The Opportunity: This role will be responsible for intaking franchise and asset integrated evidence plans and tactics, then delivering high quality RWE, RW insights or other patient-centric evidence for prioritized projects to fully the tactic or strategic pillar, as directed by their supervisor in accordance with the RWE Strategic Planning Oncology team based on cross-functional partners’ strategic priorities.
The remit spans from global and prioritized international markets, where the evidence will be used to respond to regulatory commitments / requests, HTA/government entity needs and key projects that have been prioritized in a managed work queue by the global medical strategy committee. The role is highly technical and will execute hands-on evidence generation via a combinatorial approach of cutting edge retrospective data analyses, site-based evaluations (e.g., Phase IV observational effectiveness studies, burden of illness, transmission, pathogenesis, risk factors for illness, determinants of product effectiveness and other studies), application of novel methods and technologies, and supplementation of interventional trials where appropriate with RWE through hybrid trial designs and tokenization. This will represent significant learning experience and growth for the successful candidate. The Platform will insource this work to the fullest possible extent, so prospective candidates who have outsourced work to contract research organizations need not apply.
Within the RWE Platform, a dedicated team of RWE Scientists will support the TA teams within the Oncology category, reporting to the Solid Tumor Oncology RWE Science & Epidemiology Team Lead. Leveraging their understanding of how RWE can support the entire lifecycle from molecule to marketplace, the Solid Tumor Oncology RWE Science & Epidemiology Sr Manager will deliver timely real world insights (RWI) by understanding cross-functional pipeline / asset team’s strategic objectives and timelines, collaborate with the team and RWE Biostatistics & other relevant colleagues to generate RWE, and direct creation of easy-to-understand summary reports as directed by their supervisor. They will receive mentorship to help build or advance a nuanced understanding of real world data, what fit-for-purpose data needs are for different applications, and which sources are most appropriate for completing objectives, partnering closely with the Platforms & Partnerships and Patient Advocacy & External Partnerships teams. The RWE Scientist will ensure the development of consistent business rules and standards, versioning rules as care pathways evolve.
ROLE RESPONSIBILITIES
As instructed, leads RWI for feasibility assessments, go/no-go decisions, co-design and create dashboards to inform cross-functional teams’ hypothesis generation, generate timely and detailed insights.
Collaborates with team members to build strong internal and external partnerships and act as a junior subject matter expert by providing expert consultations on all aspects of RWD studies and analyses, including feasibility assessment, objectives, study design, data source identification, protocol development, statistical analyses, and table shells.
Conduct and oversee the execution of rapid RWD-based queries and studies and effectively communicate the findings and study results to internal stakeholders using tables, visualizations, short reports, and slide decks.
Apply quality standards and processes to manage quality, consistency, usability, security, and availability of data throughout the data lifecycle; stay up to date on RWD/E best practices.
Participates actively on internal cross-functional teams, RWE Biostatistics, and other colleagues to create high-quality RWE from rigorously designed protocols.
Help to collaboratively write high-quality methods, innovative approaches, protocols, and designs.
Generate RWE through collaborations with the pipeline/asset teams (e.g., pipeline teams, Global Product Development franchise/asset teams, BU Medical affairs, HEOR, Commercial and other functions), RWE Biostatistics, and other functions as directed.
Document all requests and track progress toward project completion, create and measure quarterly ROI metrics, and ensure support to business goals.
2+ (with a master’s degree) to 3+ (Bachelor’s degree) years’ experience in the pharmaceutical industry or related field in Epidemiology, Pharmacoepidemiology, or Biostatistics roles with a substantial quantitative and computational component, other related fields or commensurate professional experience.
Proven successful track record of scientific analysis of real- world data for scientific, business, quality or other purposes
Knowledge of Electronic Health Records, medical and pharmacy claims, patient registries, patient participating research networks and other real-world data sources
Ability to critically evaluate analytic results against the literature, subject matter expert feedback or other reliable sources to ensure biological and medical credibility in alignment with cross-functional team strategy / priorities
Two or more years of experience in communicating in verbal and written form with all levels of personnel with diverse backgrounds, and able to create and deliver clear presentations to teams
Ability to work under pressure with a high level of autonomy and internal motivation and adapting rapidly within evolving digital environment
Experience with protocol development and execution for non-interventional studies using a variety of analytical techniques applied to various databases
Two or more years of hands-on experience of query and analytic languages and technologies (eg, SQL, R, SAS, IHD, Aetion) and of relevant biological and medical data standards (eg, HGNC / Entrez, ICD, CPT)
Ability to rapidly learn new domains to understand the latest scientific or medical findings and incorporate them into projects as appropriate; to interpret data dictionaries and other technical documentation
NON-STANDARD WORK SCHEDULE, TRAVEL OR ENVIRONMENT REQUIREMENTS
Up to ~5% travel
ADDITIONAL DETAILS:
Last date to apply for Job: February 16, 2024.
Relocation assistance may be available based on business needs and/or eligibility.
Sunshine Act
Pfizer reports payments and other transfers of value to health care providers as required by federal and state transparency laws and implementing regulations. These laws and regulations require Pfizer to provide government agencies with information such as a health care provider’s name, address and the type of payments or other value received, generally for public disclosure. Subject to further legal review and statutory or regulatory clarification, which Pfizer intends to pursue, reimbursement of recruiting expenses for licensed physicians may constitute a reportable transfer of value under the federal transparency law commonly known as the Sunshine Act. Therefore, if you are a licensed physician who incurs recruiting expenses as a result of interviewing with Pfizer that we pay or reimburse, your name, address and the amount of payments made currently will be reported to the government. If you have questions regarding this matter, please do not hesitate to contact your Talent Acquisition representative.
EEO & Employment Eligibility
Pfizer is committed to equal opportunity in the terms and conditions of employment for all employees and job applicants without regard to race, color, religion, sex, sexual orientation, age, gender identity or gender expression, national origin, disability or veteran status. Pfizer also complies with all applicable national, state and local laws governing nondiscrimination in employment as well as work authorization and employment eligibility verification requirements of the Immigration and Nationality Act and IRCA. Pfizer is an E-Verify employer.
Pfizer is committed to equal opportunity in the terms and conditions of employment for all employees and job applicants without regard to race, color, religion, sex, sexual orientation, age, gender identity or gender expression, national origin, disability or veteran status. Pfizer also complies with all applicable national, state and local laws governing nondiscrimination in employment as well as work authorization and employment eligibility verification requirements of the Immigration and Nationality Act and IRCA. Pfizer is an E-Verify employer.